These findings were counteracted by ET124 (Figure 7F) that significantly diminished S100B upregulation (p < 0.01 vs. AD) and attenuated overexpression of AGER, GFAP, and GJA1 genes (though not significantly vs. control or AD models). This evidence concerns the gene GJA1 and Alzheimer disease.